Table 5

Acute haemodynamic outcomes after stratification into invasive pre-procedural RV-to-PA pressure gradients

ParameterPPVIBMS+PPVIp Value
Subgroup 1 (‘mild’ RV-to-PA gradient*: 0–25 mm Hg)(n=23)(n=12)
 Pre-procedural RV-to-PA gradient, mm Hg15±715±7±1.60.84
 Change in RV-to-PA gradient, mm Hg−5±6−5±80.81
 Patients with high-pressure balloon dilatations, n1020.15
Subgroup 2 (‘moderate’ RV-to-PA gradient: 26–40 mm Hg)(n=16)(n=17)
 Pre-procedural RV-to-PA gradient, mm Hg34±533±40.37
 Change in RV-to-PA gradient, mm Hg−22±7−21±80.69
 Patients with high-pressure balloon dilatations, n14110.22
Subgroup 3 (‘severe’ RV-to-PA gradient: >40 mm Hg)(n=12)(n=20)
 Pre-procedural RV-to-PA gradient, mm Hg52±953±100.86
 Change in RV-to-PA gradient, mm Hg−36±15−39±80.56
 Patients with high-pressure balloon dilatations, n10171.00
  • Continuous data presented as mean ± SD.

  • * RV-to-PA, right ventricle to pulmonary artery. Paired invasive RV-to-PA pressure gradients enabling stratification into three groups were available in 100/108 (93%) patients.

  • BMS, bare metal stenting; PPVI, percutaneous pulmonary valve implantation.